Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Moving toward new statin guidelines in a post-JUPITER world: Principles to consider
Current Atherosclerosis Reports, 06/22/09
Ridker PM - Absolute risk reductions within JUPITER result in a number needed to treat at 5 years of 25, a value comparable or superior to that of other interventions routinely used in primary prevention, including statin therapy among those with hyperlipidemia. Although lifestyle interventions remain critical, the screening and treatment strategy tested in JUPITER is likely to impact on new guidelines for cardiovascular disease prevention.
Related Articles
CRESTOR reduced risk of cardiovascular events in women by nearly half in new analysis of JUPITER study
AstraZeneca, 11/18/09
Relevance Score: 84%%
Rosuvastatin along the cardiovascular continuum: from JUPITER to AURORA
Expert Review of Cardiovascular Therapy, 11/16/09
Relevance Score: 80%%
Treating cholesterol: Drugs and natural options
Internet Source, 10/09/09
Relevance Score: 80%%
Today in Prevention...keeping you current
Receive free subspecialty "5-minute updates" via email
Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified By National Cholesterol Education Program Risk Category
Metabolic Syndrome and Related Disorders, 11/25/09
Inflammation markers and metabolic characteristics of subjects with one-hour plasma glucose levels
Diabetes Care, 11/23/09
Low Total and Nonheme Iron Intakes Are Associated with a Greater Risk of Hypertension
The Journal of Nutrition, 11/19/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


